Body Awareness, Upper Extremity Function, and Quality of Life in Breast Cancer Survivors
NCT ID: NCT07133087
Last Updated: 2025-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
42 participants
OBSERVATIONAL
2025-05-06
2025-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to examine the effects of breast cancer treatment on upper extremity functions, body awareness, and quality of life in women who have survived breast cancer treatment, in comparison with a healthy control group. The study will be conducted at Yeditepe University Koşuyolu Hospital between May, 2025, and October, 2025. Participants will include women who have survived breast cancer treatment and a healthy control group matched based on criteria such as age and body mass index.
In the study, three separate assessments will be conducted for upper extremity functions: the "Quick Disabilities of the Arm, Shoulder, and Hand" (QuickDASH) questionnaire for upper extremity functionality, a hand dynamometer for grip strength, and the Clinometer device for shoulder joint position sense. The "Body Awareness Questionnaire" will be used to assess body awareness, and the "EORTC QLQ-C30" scale will be used for quality of life assessment. The IBM SPSS Statistics software package will be used for data analysis. In statistical analyses, a significance level of p\<0.05 will be considered.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Body Awareness and Functionality in Lymphedema
NCT06036173
Factors Affecting Functionality in Breast Cancer Survivors
NCT04245657
Gait Characteristics of Women With Breast Cancer-Related Lymphedema
NCT07011277
Combined Upper Extremity Resistance and Aerobic Exercise Training in Patients With Breast Cancer
NCT07070791
Upper Extremity Exercise Capacity Of Breast Cancer
NCT06859593
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy control group
A group of healthy subjects, matched with the breast cancer group based on criteria such as age and body mass index, will be included in the study.
No interventions assigned to this group
Breast cancer group
Women who have survived Stage 0-III breast cancer will be included in the study.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being between the ages of 25 and 75
* Having been diagnosed with Stage 0-III breast cancer
* Having completed primary treatments (surgery, chemotherapy, and/or radiation therapy) no more than 6 months prior to the assessment date
* Having received medical clearance from a physician
* Having undergone either breast-conserving surgery or mastectomy due to breast cancer
* Willingness to participate in the study voluntarily
* Being a woman
* Having a body mass index (BMI) within ±3 kg/m² of the breast cancer survivor group
* Being within ±5 years of age compared to the breast cancer survivor group
* Matching hand dominance with the breast cancer survivor group
Exclusion Criteria
* Having a history of neuromuscular dysfunction
* Using medications that may affect neuromuscular performance
* Having a history of neuromuscular dysfunction
* Using medications that may affect neuromuscular performance
* Having a history of rehabilitation due to upper extremity, thoracic, or cervical musculoskeletal disorders within the last 6 months
25 Years
75 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Halic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seda Saka, PhD
Role: STUDY_DIRECTOR
Haliç University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Halic University
Istanbul, , Turkey (Türkiye)
Yeditepe Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ssaka10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.